Filters

Latest News

2018-12-10 13:14:17

Unjela Kaleem joins global pharma association as Director of Communications

Geneva, 10 December 2018 – IFPMA, the global research-based biopharmaceutical industry association, is pleased to announce Ms Unjela Kaleem as ...

Read More

2018-12-05 12:00:49

R&D biopharmaceutical industry revamp ethical code to apply as base line of industry behavior worldwide

New R&D biopharmaceutical industry Code of Practice comes into effect on 1 January 2019. Changes ...

Read More

2018-12-04 17:17:22

David A. Ricks Elected New President of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

David A. Ricks, Chairman and Chief Executive Officer, Eli Lilly and Company, takes over as ...

Read More

2018-11-16 06:30:08

Pharma industry launches call for coalition of countries to pilot new incentives for antibiotic R&D

16 November, Geneva – The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) draws attention ...

Read More

2018-11-13 09:35:59

The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance (AMR) has made strides in 2018 and calls for a coordinated and multi-pronged response from all stakeholders

The AMR Industry Alliance has made major strides in 2018 taking action across four different ...

Read More

2018-10-29 10:25:29

The R&D biopharmaceutical industry supports the Astana Declaration and renewed political commitment towards the importance of primary health care

26 October 2018, Astana – The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the ...

Read More

2018-09-27 17:57:02

The R&D-based biopharmaceutical industry welcomes the UN Declaration on NCDs and calls for innovative financing models and multi-sectoral collaboration

New York, 27 September 2018 – As an official UN interlocutor that shares knowledge and ...

Read More

Latest Statement

2018-10-12 14:58:26

R&D biopharmaceutical industry at WHS 2018 urges finding joint solutions to achieve better health outcomes including forging impactful partnerships

Sunday, 14 October 2018, Berlin – The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the body accredited by the ...

Read More

2018-10-04 16:50:33

Global Business Coalition - Knowledge Partners of Global Health & Human Resources Knowledge Partnership Issue Statement

New York, 27 September 2018 – As an official UN ...

Read More

2018-09-27 17:58:18

R&D-based biopharmaceutical industry welcomes UN Declaration on NCDs

New York, 27 September 2018 – As an official UN ...

Read More

2018-09-26 22:55:57

R&D-based biopharmaceutical industry welcomes UN Declaration on TB

New York, 27 September 2018 – As an official UN ...

Read More

2018-09-20 10:31:00

68th WHO Regional Committee for Europe: Roadmap for access 2019–2023: Comprehensive support for access to medicines and vaccines

New York, 27 September 2018 – As an official UN ...

Read More

2018-08-30 14:17:00

WHO Afro 68 agenda item 12: Status of implementation of the four time-bound commitments on noncommunicable diseases in the Africa region

New York, 27 September 2018 – As an official UN ...

Read More

2018-08-30 14:16:42

WHO Afro 68 agenda item 14: Roadmap for access 2019–2023: Comprehensive support for access to medicines and vaccines

New York, 27 September 2018 – As an official UN ...

Read More

mailto:s.kaenzig@ifpma.org +41 22 338 32 49
direct line
Twitter skaenzig

Sadia Kaenzig - Communications Manager

Sadia manages communications on issues including regulatory, intellectual property protection, trade and the economic footprint of the research-based pharmaceutical industry, research and development ecosystem and innovation, vaccines including influenza vaccines, and biotherapeutics.

mailto:m.depol@ifpma.org +41 22 338 32 20
direct line
Twitter @MorganePol

Morgane De Pol - Communications and Public Affairs

Morgane manages communications on issues including the research-based pharmaceutical industry’s commitment to achieving sustainable and inclusive development, advancing Universal Health Coverage, designing transformational partnerships to build healthier societies, boosting innovation for neglected tropical diseases, expanding access to high quality treatments for infectious and chronic diseases, fighting counterfeit medicines, and promoting resilient and efficient health systems.

A shared commitment to global health

Our Brouchure

2015 Edition

A shared commitment to global health

At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.


Our Logo

Full colour EPS format

Our Logo

Full colour PNG format


FULL Name LOGO

Full colour EPS format


FULL Name LOGO

Full colour PNG format

Hot Topic

Pharmacovigilance: Do your bit, play your part!

Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is

Read More

Interview

IFPMA 2015 interview series 'Biodiversity, human health, and pharma'

A must-watch: Dr Manisha A. Desai, assistant general patent counsel at Eli Lilly and Company, gives her take on the importance of the Convention of Biodiversity and the Nagoya Protocol for the pharma industry. What's key is to

Read More

Our Blog

Latest Tweets

.@ThomasCueni at @BusinessatOECD Forum "With the adoption of digital technologies comes the empowered patient who,… https://t.co/fKL1CDDUKS
5 10
  @IFPMA
RT @AlzDisInt: Deputy CEO Chris Lynch with @ThomasCueni from @IFPMA and @ieuan_clay from @Novartis talking about digital health; from produ…
5
  @IFPMA
Collaborations can speed up progress towards #UHC. From training #HCPs, building infrastructures & pioneering ways… https://t.co/3UkzVJ4yt4
3 3
  @IFPMA
How can we make #UHC truly universal? We heard great insights from @IlonaKickbusch, @DrAxelrod_WHO, Dr Odame… https://t.co/G2udP8EgqE
1
  @IFPMA
What is the key for #globalhealth security and how can we prepare for emergencies? Dr Princess Nothemba Simelela… https://t.co/R35Vd66rsn
2
  @IFPMA